To mimic this combination of genetic events, we used genomic editing technology to knock out TNFAIP3 in MYD88L265P non-Hodgkin’s lymphoma (NHL) cell lines. This evidence concerns the gene TNFAIP3 and non-Hodgkin lymphoma.